THURSDAY, NOVEMBER 20th – 54th Floor, Bow Tower, Calgary |
| 7:45 AM | Registration |
| 8:00 AM – 9:00 AM | Continental Breakfast |
| 9:00 AM – 9:40 AM | Welcome Address – Dr. Steven Yip & Dr. Pinaki Bose, POET Congress Co-Chairs
· Dr. Todd Anderson, Cumming School of Medicine |
| 9:40 AM – 10:10 AM | KEYNOTE PRESENTATION – Chair: Dr. Pinaki Bose
Keynote: Next Generation ctDNA Adaptive Clinical Trials in Breast Cancer –Dr. Pedram Razavi, Memorial Sloan Kettering Cancer Centre, NY |
| 10:10 AM – 10:20 AM | Questions & Answers |
| 10:20 AM – 11:10 AM | SESSION 1: Precision Oncology and Clinical Trials Chair: Dr. Steven Yip |
| 10:20 AM – 10:40 AM | Title TBD – Dr. Gwyn Bebb, AB |
| 10:40 AM – 10:45 AM | Questions & Answers |
| 10:45 AM – 11:05 AM | The role of IFNg in CAR-T trials: Is more better? – Dr. Matthew Frigault, Mass General Brigham, MA |
| 11:05 AM – 11:10 AM | Questions & Answers |
| 11:10 AM – 11:30 AM | Coffee Break |
| 11:30 AM – 12:45 PM | SESSION 1 Continued |
| 11:30 AM – 11:50 PM | Targeting the AR Pathway, Novel Agents and Biomarkers – Dr. Daniel Khalaf, Sunnybrook Hospital, ON |
| 11:50 PM – 11:55 PM | Questions & Answers |
| 11:55 PM – 12:15 PM | Dr. Faisal Khan, University of Calgary, AB |
| 12:15 PM – 12:20 PM | Questions & Answers |
| 12:20 PM – 12:40 PM | Integrating ctDNA into Clinical Trials: Advancing Precision Oncology from Drug development to MRD interception – Dr. Enrique Sanz Garcia, Princess Margaret Cancer Centre, ON |
| 12:40 PM – 12:45 PM | Questions & Answers |
| 12:45 PM – 2:00 PM | Lunch |
| 2:05 PM – 2:55 PM | SESSION 2: Liquid Biopsy-Based Approaches in Precision Oncology Chair: TBD |
| 2:05 PM – 2:25 PM | Androgen Receptor Gene Alterations in Treatment-Resistant Prostate Cancer – Dr. Alex Wyatt, University of British Columbia, BC |
| 2:25 PM – 2:30 PM | Questions & Answers |
| 2:30 PM – 2:50 PM | Beyond Mutations: ctDNA to Monitor Treatment Response and Disease Progression – Dr. Julia V. Burnier, McGill University, QC |
| 2:50 PM – 2:55 PM | Questions & Answers |
| 2:55 PM – 3:25 PM | Coffee Break |
| 3:25 PM – 4:15 PM | SESSION 2 Continued |
| 3:25 PM – 3:45 PM | Whole Genome Sequencing Enables Ultra-sensitive Cancer Detection – Alexandre Pellan-Cheng, ETS Montréal, QC |
| 3:45 PM – 3:50 PM | Questions & Answers |
| 3:50 PM – 4:10 PM | From Atlas to Assay: Interpreting Liquid Biopsies through Large-Scale Reference Data – Dr. Eric Zhao, University Health Network, ON |
| 4:10 PM – 4:15 PM | Questions & Answers |
| 4:15 – 4:25 PM | Day 1 Closing Remarks – Drs. Steven Yip & Pinaki Bose, POET Co-Chairs |
| 4:30 PM – 6:00 PM | POET Reception Sky Garden, 54th Floor, Bow Tower |
| 6:00 PM – 8:30 PM | POET Welcome Dinner INNOVATION IN PRECISION ONCOLOGY Co-Chairs Dr. Steven Yip & Dr. Pinaki Bose Mountain View Room, 54th Floor, Bow Tower ACF Opening Remarks – ACF Representative Keynote: Personalized Oncogenomic Medicine Approaches to Expand Treatment Options for Cancer Patients – Dr. Marco Marra, Canada’s Michael Smith Genome Sciences Centre, BC Keynote: When the Genomics Becomes Personal: Lessons from Science and Survival – Dr. Catalina Lopez Correa, Genome Canada, Ottawa, ON |
FRIDAY, NOVEMBER 21st – 54th Floor, Bow Tower, Calgary |
| 8:00 AM – 9:00 AM | Registration & Continental Breakfast |
| 9:00AM – 9:05 AM | Opening Remarks – Drs. Steven Yip & Pinaki Bose, POET Co-Chairs |
| 9:05 AM – 10:20 AM | SESSION 3: Microbiome in Precision Oncology Chair: Dr. Kathy McCoy |
| 9:05 AM – 9:25 AM | Dr. Thomas Gajewski, University of Chicago, IL |
| 9:25 AM – 9:30 AM | Questions & Answers |
| 9:30 AM – 9:50 AM | Role of the Gut Microbiome in CAR-T Cell Immunotherapy Against Hematologic Malignancies – Dr. Christoph Stein-Thöringer, University Clinic Tuebingen, M3 Research Institute, Austria |
| 9:50 AM – 9:55 AM | Questions & Answers |
| 9:55 AM – 10:15 AM | Modification of the Gut Microbiome to Improve Outcomes to Immunotherapy in Patients with Cancer – Dr. Arielle Elkrief, CRCHUM, QC |
| 10:15 AM – 10:20 AM | Questions & Answers |
| 10:20 AM – 10:50 AM | Making the Complex Simple: “Microbiome Therapy” for Cancer Using Metabolites Derived from Gut Microbes – Dr. Douglas Mahoney, University of Calgary, AB |
| 10:50 AM – 10:55 AM | Questions & Answers |
| 10:55 AM – 11:25 AM | Coffee Break |
| 11:25 AM – 12:45 PM | SESSION 4: Immuno-Oncology and Cellular Therapy Chair: Dr. Nicolas Jacquelot |
| 11:25 AM – 11:45 AM | Empowering Immunity: Metabolic Regulation of Anti-tumor T Cell Function – Dr. Ramon Klein Geltink, University of British Columbia, BC |
| 11:45 AM – 11:50 AM | Questions & Answers |
| 11:50 PM – 12:10 PM | Dr. Nizar J. Bahlis, University of Calgary, AB |
| 12:10 PM – 12:15 PM | Questions & Answers |
| 12:15 PM – 12:35 PM | Potential Role for GD T Cells in Immunotherapy – Dr. Pamela Ohashi, University Health Network, ON |
| 12:35 PM – 12:40 PM | Questions & Answers |
| 12:45 PM – 2:00 PM | Lunch |
| 2:00 PM – 4:05 PM | SESSION 5: Precision Oncology and Artificial Intelligence Chair: Dr. Ali Bashashati |
| 2:00 PM – 2:20 PM | All Lesions Matter: Reimagining Response with AI and Radiomics – Dr. Benjamin Haibe-Kains, University Health Network, ON |
| 2:20 PM – 2:25 PM | Questions & Answers |
| 2:25 PM – 2:45 PM | Harnessing Machine Learning to Advance Cancer Biomarker Science – Dr. Ali Bashashati, University of British Columbia, BC |
| 2:45 PM – 2:50 PM | Questions & Answers |
| 2:50 PM – 3:15 PM | Coffee Break |
| 3:15 PM – 3:35 PM | Reading and Writing the Language of Genome – Dr. Hani Goodarzi, Arc Institute, CA |
| 3:35 PM – 3:40 PM | Questions & Answers |
| 3:40 PM – 4:00 PM | Multimodal Generative AI for Precision Health – Dr. Hoifung Poon, University of Washington Medical School, WA |
| 4:00 PM – 4:05 PM | Questions & Answers |
| 4:05 PM – 4:15 PM | Day 2 Closing Remarks – Drs. Steven Yip & Pinaki Bose, POET Co-Chairs |
